DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

Phase 3

Completed

Conditions: Cardiovascular Diseases
Angina, Unstable
Depression
Heart Diseases
Myocardial Infarction

Interventions: Drug: Sertraline/omega-3
Drug: Sertraline/Corn Oil

First Posted Date: 2005-07-01

Last Posted Date: 2012-09-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 122

Registration Number: NCT00116857

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States

Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: letrozole
Procedure: conventional surgery

First Posted Date: 2004-06-11

Last Posted Date: 2016-09-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 115

Registration Number: NCT00084396

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 2

Completed

Conditions: Drug/Agent Toxicity by Tissue/Organ
Radiation Toxicity
Lung Cancer

First Posted Date: 2004-05-25

Last Posted Date: 2013-05-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 34

Registration Number: NCT00004176

Locations: 🇺🇸
Rocky Mountain Cancer Center, Denver, Colorado, United States
🇺🇸
Washington University Barnard Cancer Center, Saint Louis, Missouri, United States
🇺🇸
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States

and more 1 locations

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy

Phase 1

Terminated

Conditions: Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions: Drug: arsenic trioxide
Drug: tretinoin

First Posted Date: 2004-05-20

Last Posted Date: 2013-02-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 5

Registration Number: NCT00006220

Locations: 🇺🇸
Washington University Barnard Cancer Center, Saint Louis, Missouri, United States

Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer

Not Applicable

Completed

Conditions: Liver Cancer

Interventions: Procedure: 18F-Fluorodeoxyglucose-PET (FDG-PET)
Procedure: 11Carbon-Acetate-PET

First Posted Date: 2004-04-08

Last Posted Date: 2013-04-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 31

Registration Number: NCT00081094

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

Phase 1

Completed

Conditions: Sarcoma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: pegylated liposomal doxorubicin hydrochloride
Drug: PSC 833

First Posted Date: 2004-02-16

Last Posted Date: 2013-04-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 14

Registration Number: NCT00003207

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial

Phase 3

Completed

Conditions: Sickle Cell Anemia
Stroke

Interventions: Procedure: transfusion therapy

First Posted Date: 2003-11-13

Last Posted Date: 2016-02-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 196

Registration Number: NCT00072761

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

Phase 3

Completed

Conditions: Bipolar Disorder

Interventions: Drug: Lithium carbonate
Drug: Valproate
Drug: Risperidone

First Posted Date: 2003-04-08

Last Posted Date: 2013-04-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 379

Registration Number: NCT00057681

Locations: 🇺🇸
University of Pittsburgh/WPIC, Pittsburgh, Pennsylvania, United States
🇺🇸
Johns Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States

and more 2 locations

Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia

Phase 1

Completed

Conditions: Leukemia

Interventions: Drug: arsenic trioxide

First Posted Date: 2003-01-27

Last Posted Date: 2013-04-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 13

Registration Number: NCT00008697

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Treatment of Depression After Coronary Bypass Surgery

Not Applicable

Completed

Conditions: Depression
Coronary Disease

Interventions: Behavioral: Cognitive behavior therapy
Behavioral: Supportive Stress Management

First Posted Date: 2002-07-26

Last Posted Date: 2013-07-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 123

Registration Number: NCT00042198

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy